Skip to main content
. 2014 Jul 24;2(6):1035–1042. doi: 10.3892/mco.2014.358

Figure 5.

Figure 5

Overall survival time of 583 lung cancer patients from Nagoya City University studied in reference to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) single-nucleotide polymorphism rs231775 gene status. The survival time of the patients with +49 AA CTLA-4 (●; n=83, 21 succumbed) and the patients with +49 GA or GG CTLA-4 (○; n=500, 140 succumbed) was not significantly different (log-rank test, P=0.6861).